Home › Forums › Main Forum › Experts Corner › Summary of EASL Recommendations on Treatment of Hep C 2016
Here is the Debrief Recording of EASL Recommendations on Treatment of Hepatitis C 2016. It’s 8 minutes but the first 3 minutes is pre-amble so skip it if you’re impatient…..
[video]https://www.youtube.com/watch?v=ODogH00Y6LA[/video]
YMMV
I had watched this before and did not hear the advice that these recommendations can be downloaded, I assume in pdf form.
I expect that having this document to hand when seeing your G.P. or specialist would help the conversation – a LOT.
Just a suggestion that may head off any WTF moments.
J.
This may be helpful:
http://www.easl.eu/medias/cpg/HCV2016/English-report.pdf
BTW What kind of retreatement are you going to follow now?
GT 3a Contracted: October 2008 Diagnosed: March 2009 First treatement: VL 250.000 IU/ml Fibrosis F0 Start: November 2010 Copegus+Pegasys (24 weeks) EOT: VL UND SVR24: VL DETECTED June 2016 Fibrosis F2 (9.1 kPa) VL 1.230.000 IU/ml Second treatement: SoviHep+DaciHep (24 weeks) Start: 13.08.2016 VL UND: 30.08.2016 VL UND: 27.01.2017 (EOT) EOT+4 weeks: AlAT 9.8 SVR4 EOT+8 weeks: AlAT 9.7 EOT+12 weeks: AlAT 7.0 EOT+28 weeks: AlAT 7.6 SVR28